Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 243 across all filing types
Latest filing 2015-08-26 Earnings Release
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Bio-Gate mit starkem Umsatzwachstum im ersten Halbjahr 2015
Earnings Release Classification · 100% confidence The document is titled 'Bio-Gate mit starkem Umsatzwachstum im ersten Halbjahr 2015' and explicitly discusses financial performance metrics (Umsatz, EBITDA, EBIT, Konzernverlust) for the 'ersten sechs Monaten' (first six months) of the fiscal year 2015. It provides detailed financial figures and operational highlights for a period shorter than a full year. This content aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it mentions the 'vollständige... Halbjahresbericht 2015 ist auf der Homepage... verfügbar' (the complete 2015 half-year report is available on the homepage), the provided text itself contains the core results, making it the report content rather than just a publication announcement (RPA). H1 2015
2015-08-26 German
Bio-Gate AG: Bio-Gate schliet Barkapitalerhohung erfolgreich ab
Share Issue/Capital Change Classification · 99% confidence The document text is a press release dated June 22, 2015, titled "Bio-Gate schließt Barkapitalerhöhung erfolgreich ab" (Bio-Gate successfully closes cash capital increase). The content explicitly details the placement of new shares, the resulting capital increase, the gross proceeds (approx. 0.6 million Euro), and the intended use of the funds (growth financing). This directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific corporate finance action.
2015-06-22 German
Bio-Gate AG vollzieht Segmentwechsel
Delisting Announcement Classification · 99% confidence The document is a short press release dated June 10, 2015, announcing that Bio-Gate AG is changing its stock exchange segment from the Entry Standard in Frankfurt to the 'Freiverkehr' (Free Market) in Munich. It explicitly mentions that the company will voluntarily continue providing semi-annual reports ('Halbjahresberichterstattung wird auf freiwilliger Basis fortgeführt'). Since the document is short (under 5,000 characters) and its primary function is to announce a corporate action (segment change) and the continuation of reporting rather than being the report itself, it fits best as a general regulatory announcement or a report publication announcement. Given that it announces the continuation of reporting (which implies future reports) and details a significant corporate event (exchange segment change), it is classified as a Regulatory Filing (RNS) as it is a general corporate news item distributed via DGAP that doesn't fit the more specific categories like CAP, SHA, or DIV. It is not an ER, IR, or 10-K, but rather an announcement about the company's status and future reporting intentions.
2015-06-10 German
Bio-Gate AG mit erfolgreichem Jahresstart
Earnings Release Classification · 100% confidence The document is a press release dated May 12, 2015, titled "Bio-Gate AG mit erfolgreichem Jahresstart" (Bio-Gate AG with a successful start to the year). It details preliminary operational and revenue highlights for the period ending April 2015, mentioning specific business segments (Veterinary, Coatings, Finished Products) and outlook for the full year 2015. This content structure—providing key financial and operational updates for a recent period (not the full year or a comprehensive quarterly report)—is characteristic of an Earnings Release (ER). It is not a full Annual Report (10-K), a comprehensive Interim Report (IR), or merely an announcement of a report (RPA). Q1 2015
2015-05-12 German
Bio-Gate AG: Bio-Gate AG kundigt Segmentwechsel an
Delisting Announcement Classification · 99% confidence The document is a press release dated April 28, 2015, announcing that Bio-Gate AG is applying to withdraw its shares from the Entry Standard segment of the Frankfurt Stock Exchange and focus trading on the Open Market (Freiverkehr) in Munich. It also provides a brief update on Q1 performance and confirms the 2015 forecast. This type of announcement, which deals with corporate actions, segment changes, and brief financial updates, does not fit neatly into the specific categories like 10-K, ER, or IR. Since it is a general corporate news release about a structural/listing change and includes a brief business update, it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) due to the segment change impacting listing status. However, RNS is the designated fallback for miscellaneous regulatory announcements that don't fit elsewhere, and this is primarily a notice about a listing change and general business status update, rather than a dedicated financing event (CAP) or a formal earnings release (ER). Given the nature of the announcement (segment change and brief operational update), RNS is the most appropriate general classification for non-standard regulatory news.
2015-04-28 German
Bio-Gate AG gibt die Jahreszahlen fur 2014 bekannt
Earnings Release Classification · 100% confidence The document is titled "Bio-Gate AG gibt die Jahreszahlen für 2014 bekannt" (Bio-Gate AG announces annual figures for 2014) and contains key financial metrics for the full fiscal year 2014, including revenue, net loss, EBITDA, and cash flow, along with management outlook for 2015. This content strongly indicates the release of annual financial results. However, the document is structured as a news release/corporate announcement (published via DGAP) summarizing the results, rather than the comprehensive, audited Annual Report (10-K) itself. The presence of the note, "Hinweis: Der vollständige Geschäftsbericht 2014 der Bio-Gate AG ist auf der Homepage unter www.bio-gate.de abrufbar," confirms this is an announcement of the results, not the full report. Therefore, it best fits the Earnings Release (ER) category, which covers the initial announcement of periodical financial results (key highlights). It is not a comprehensive Interim Report (IR) as it covers the full year, and it is not the 10-K. FY 2014
2015-04-01 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.